Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Effect of remote ischaemic preconditioning on troponin release after PCI is yet to be established
    • Stephen P Hoole, Specialist Registrar
    • Other Contributors:
      • Sadia N Khan, Patrick M Heck and David P Dutka

    Dear Editor,

    We read with interest the recent article published by Iliodromitis et. al.(1), but do not agree with the conclusions drawn by the authors. The study appears to be under-powered to draw meaningful conclusions as to the therapeutic value of remote ischaemic preconditioning, and certainly the size of the study precludes a subgroup analysis of the role of statins. The authors do not state the actual number...

    Show More
    Conflict of Interest:
    None declared.